Advanced search
Publication Cover
Scandinavian Journal of Rheumatology Volume 51, 2022 - Issue 5
Submit an article Journal homepage
174
Views
7
CrossRef citations to date
0
Altmetric
Letters

Self-limiting reactive disease mimicking polymyalgia rheumatica following Moderna COVID-19 vaccine

AW Nielsen1 Department of Rheumatology, Aarhus University Hospital, Aarhus, Denmark;2 Department of Clinical Medicine, Aarhus University, Aarhus, DenmarkCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-8180-6871View further author information
ORCID Icon,
IT Hansen1 Department of Rheumatology, Aarhus University Hospital, Aarhus, Denmark;2 Department of Clinical Medicine, Aarhus University, Aarhus, DenmarkView further author information
,
LC Gormsen2 Department of Clinical Medicine, Aarhus University, Aarhus, Denmark;3 Department of Nuclear Medicine and PET, Aarhus University Hospital, Aarhus, DenmarkORCID Iconhttps://orcid.org/0000-0002-0144-1305View further author information
ORCID Icon,
E-M Hauge1 Department of Rheumatology, Aarhus University Hospital, Aarhus, Denmark;2 Department of Clinical Medicine, Aarhus University, Aarhus, DenmarkORCID Iconhttps://orcid.org/0000-0003-2562-9174View further author information
ORCID Icon &
KK Keller1 Department of Rheumatology, Aarhus University Hospital, Aarhus, Denmark;2 Department of Clinical Medicine, Aarhus University, Aarhus, DenmarkORCID Iconhttps://orcid.org/0000-0003-2474-3389View further author information
ORCID Icon
Pages 411-413 | Accepted 25 Apr 2022, Published online: 06 Jun 2022

References

  • Dasgupta B, Cimmino MA, Kremers HM, Schmidt WA, Schirmer M, Salvarani C, et al. 2012 Provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative. Arthritis Rheum 2012;64:943–54.
  • Henckaerts L, Gheysens O, Vanderschueren S, Goffin K, Blockmans D. Use of 18F-fluorodeoxyglucose positron emission tomography in the diagnosis of polymyalgia rheumatica – a prospective study of 99 patients. Rheumatology (Oxford) 2018;57:1908–16.
  • Baden LR, El Sahly HM, Essink B, Kotloff K, Frey S, Novak R, et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N Engl J Med 2021;384:403–16.
  • Manzo C, Natale M, Castagna A. Polymyalgia rheumatica as uncommon adverse event following immunization with COVID-19 vaccine: a case report and review of literature. Aging Med (Milton) 2021;4:234–8.
  • Izuka S, Komai T, Natsumoto B, Shoda H, Fujio K. Self-limited polymyalgia rheumatica-like syndrome following mRNA-1273 SARS-CoV-2 vaccination. Intern Med 2021;61:903–6.
  • Mettler C, Jonville-Bera AP, Grandvuillemin A, Treluyer JM, Terrier B, Chouchana L. Risk of giant cell arteritis and polymyalgia rheumatica following COVID-19 vaccination: a global pharmacovigilance study. Rheumatology (Oxford) 2022;61:865–7.
  • Kremers HM, Reinalda MS, Crowson CS, Zinsmeister AR, Hunder GG, Gabriel SE. Relapse in a population based cohort of patients with polymyalgia rheumatica. J Rheumatol 2005;32:65–73.
  • Brault C, Riis AH, Mor A, Duhaut P, Thomsen RW. Does low risk of infections as a marker of effective immunity predict increased risk of subsequent giant cell arteritis or polymyalgia rheumatica? A Danish population-based case-control study. Clin Epidemiol 2018;10:1533–43.
  • Siddiqi N, Gulati G, Ware AE. Polymyalgia rheumatica and autoimmune inflammatory syndrome induced by adjuvants following administration of influenza vaccine. J Clin Rheumatol 2018;24:410–2.
  • Auzary C, Le Thi Huong D, Delarbre X, Sbai A, Lhote F, Papo T, et al. Subacute bacterial endocarditis presenting as polymyalgia rheumatica or giant cell arteritis. Clin Exp Rheumatol 2006;24:S38–40.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.